Industries
Nuclear Energy
All research in Nuclear Energy — 5 reports.
31/100
X-Energy: Real Nuclear-Licensing Progress, Priced Like a Decade of Milestones Is Already Won
X-Energy is a newly IPO'd, pre-commercial advanced-nuclear reactor and fuel developer, monetizing the Xe-100 reactor design and TRISO-X fuel manufacturing through DOE cost-share funding and development-stage services rather than power sales. Rating Watch: at $18.32 the stock already discounts a meaningful share of first-of-a-kind execution success, with an ideal buy zone of $9-11 requiring either a real price pullback or bankable proof that the Seadrift project and TX-1 fuel plant convert from milestones into commercial economics.
32/100
NANO Nuclear Energy: A Well-Capitalized Microreactor Option, Priced Ahead of Commercial Proof
NANO Nuclear is a pre-revenue microreactor developer, best read as a listed basket of nuclear options funded by an unusually large cash balance, with its KRONOS reactor now the lead asset in formal NRC review. Total liquidity of 568.7 million USD at March 2026 removes near-term financing stress, but there is still no product revenue and commercialization is only an early-2030s aspiration. Rating Hold: the cash pile makes permanent loss less likely, yet at 20.75 USD the price already pays for years of regulatory progress that has not yet happened.
37/100
Oklo (OKLO.US) Zen Horizon Research Report
Oklo is an advanced nuclear fission developer founded in 2013 by two MIT nuclear engineering PhDs and taken public on the NYSE in 2024 through Sam Altman's SPAC, with its sodium-cooled fast reactor Aurora (75 MWe) and a build-own-operate model that sells power rather than reactors to AI data centers under long-term PPAs. The core thesis is real policy access and real cash, but a pre-revenue company with a Q1 2026 net loss of $33M, $2.54B of cash, and DOE reactor-pilot selection is already carrying a very long-dated option value. Report Rating Watch: an excellent story with no margin of safety at the current price.
42/100
Centrus Energy Zen Horizon Framework Deep-Dive Research
Centrus Energy is the only U.S.-owned uranium enricher using domestic centrifuge technology and the only HALEU producer currently in operation, making it a rare policy-positioned name in the AI power demand to nuclear revival to nuclear fuel chain. The core thesis is strategically compelling, but roughly 90% of net income comes from cash interest, core operating margin is only about 7%, and about $2.4B of its $3.9B backlog is contingent on capacity buildout and financing. Research rating Watch: the strategic value is real, but the margin of safety in price has not yet arrived.
46/100
BWX Technologies (BWXT) Zen Horizon Research Report
BWX Technologies is the de facto sole-source manufacturer of U.S. Navy nuclear propulsion reactors, cores, and fuel, with a nearly impregnable moat. The core thesis is anchored by roughly $7 billion of government backlog and rigid multi-year national programs such as the Columbia- and Virginia-class submarines, with additional nuclear renaissance options in Project Pele microreactors, BWRX-300 reactor pressure vessels, and medical isotopes. Report rating Watch: a world-class business is already priced close to full value, leaving limited margin of safety before option value converts into earnings.